2022
DOI: 10.1007/7854_2022_369
|View full text |Cite
|
Sign up to set email alerts
|

The Immune System and Depression: From Epidemiological to Clinical Evidence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 110 publications
0
1
0
Order By: Relevance
“…Inflammation is a proposed contributor to the pathophysiology of depression, however, the potential contribution of neuroinflammatory mechanisms to depression is still not fully elucidated [ 1 ]. Biomarkers of neuroinflammation include cytokines (here used as a term referring to cytokines, interferons (INF), interleukins (IL), chemokines, and the tumor necrosis factor (TNF) family [ 2 ]) that are key modulators of inflammation secreted from a broad variety of cells (both immune cells and others) [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…Inflammation is a proposed contributor to the pathophysiology of depression, however, the potential contribution of neuroinflammatory mechanisms to depression is still not fully elucidated [ 1 ]. Biomarkers of neuroinflammation include cytokines (here used as a term referring to cytokines, interferons (INF), interleukins (IL), chemokines, and the tumor necrosis factor (TNF) family [ 2 ]) that are key modulators of inflammation secreted from a broad variety of cells (both immune cells and others) [ 3 ].…”
Section: Introductionmentioning
confidence: 99%